IGF1 and neoplasm: We recently reported that EMMPRIN promotes tumor glycolysis through monocarboxylate transporters (MCTs) [12], and regulates tumor angiogenesis through controlling the expression of insulin-like growth factor-I (IGF-I), in addition to VEGF [13].